Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department

Objectives We evaluated the characteristics and sought risk factors for hospitalization in children who return to the emergency department within 7 days of discharge after oral or intravenous ondansetron treatment for vomiting. The secondary aim was to determine whether the diagnosis of any serious...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Paediatric drugs 2023-03, Vol.25 (2), p.233-238
Hauptverfasser: Palnizky Soffer, Gili, Schnapp, Zeev, Miroluz, Dana, Rimon, Ayelet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 238
container_issue 2
container_start_page 233
container_title Paediatric drugs
container_volume 25
creator Palnizky Soffer, Gili
Schnapp, Zeev
Miroluz, Dana
Rimon, Ayelet
description Objectives We evaluated the characteristics and sought risk factors for hospitalization in children who return to the emergency department within 7 days of discharge after oral or intravenous ondansetron treatment for vomiting. The secondary aim was to determine whether the diagnosis of any serious condition had been delayed as the result of discharge after ondansetron treatment. Methods This retrospective analysis of the medical records of children who had been treated for vomiting with ondansetron in a tertiary care pediatric emergency department and revisited the emergency department within 7 days was performed between 2017 and 2019. We compared demographic and clinical features as well as management between hospitalized and discharged patients, focusing upon potentially delayed diagnoses of serious conditions. Results Fifty of the 89 ondansetron-treated children (56.2%) who revisited the emergency department were discharged home after their second emergency department visit and the remaining 39 (43.8%) were hospitalized. No parameter of the management of the first visit was predictive of the outcome of the revisit. Five revisit patients (5.6%) were newly diagnosed with a serious condition, with intussusception and ovarian torsion being the most substantial time-sensitive delays (the other diagnoses were pneumonia and aseptic meningitis). Conclusions Physicians assessing patients who had been treated with ondansetron as supportive care for vomiting at an earlier visit to the pediatric emergency department should consider alternative diagnoses despite initial clinical improvement. No definitive risk factor for readmission was identified, but a high level of alertness to a possible meningeal or acute abdominal source is imperative.
doi_str_mv 10.1007/s40272-022-00556-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2777434187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2777434187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-6c73e5c474f56d16e981c22600fa79773a436bdeee86a011ad07a78dc5b98f413</originalsourceid><addsrcrecordid>eNp9kM1uGyEURlHVqPlpX6CLCqnrSS8wwMwyctwmUqREStotwnDHIcqAC2NF3ufBg-003WWBQJfvfFc6hHxlcMoA9I_SAte8AV4PSKka-YEcMab7hgPrP-7ebSM73R2S41IeAJgWin8ih0KpXgGXR-T5PNhlTCUUmgZ6izmkdaGzFH2YQoqFnuOj3aCnIdKzUpILdjunT2G6p9fR21hwynVwl9FOI8aJDinTP2msfFxuseke6Q36Cubg6HzEvMToNrV5ZfMO-UwOBvtY8MvrfUJ-_5zfzS6aq-tfl7Ozq8YJgKlRTguUrtXtIJVnCvuOOc4VwGB1r7WwrVALj4idssCY9aCt7ryTi74bWiZOyPd97yqnv2ssk3lI6xzrSsO11q1oWadriu9TLqdSMg5mlcNo88YwMFvxZi_eVPFmJ97ICn17rV4vRvRvyD_TNSD2gVK_4hLz_93v1L4Ax6qP9g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2777434187</pqid></control><display><type>article</type><title>Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Palnizky Soffer, Gili ; Schnapp, Zeev ; Miroluz, Dana ; Rimon, Ayelet</creator><creatorcontrib>Palnizky Soffer, Gili ; Schnapp, Zeev ; Miroluz, Dana ; Rimon, Ayelet</creatorcontrib><description>Objectives We evaluated the characteristics and sought risk factors for hospitalization in children who return to the emergency department within 7 days of discharge after oral or intravenous ondansetron treatment for vomiting. The secondary aim was to determine whether the diagnosis of any serious condition had been delayed as the result of discharge after ondansetron treatment. Methods This retrospective analysis of the medical records of children who had been treated for vomiting with ondansetron in a tertiary care pediatric emergency department and revisited the emergency department within 7 days was performed between 2017 and 2019. We compared demographic and clinical features as well as management between hospitalized and discharged patients, focusing upon potentially delayed diagnoses of serious conditions. Results Fifty of the 89 ondansetron-treated children (56.2%) who revisited the emergency department were discharged home after their second emergency department visit and the remaining 39 (43.8%) were hospitalized. No parameter of the management of the first visit was predictive of the outcome of the revisit. Five revisit patients (5.6%) were newly diagnosed with a serious condition, with intussusception and ovarian torsion being the most substantial time-sensitive delays (the other diagnoses were pneumonia and aseptic meningitis). Conclusions Physicians assessing patients who had been treated with ondansetron as supportive care for vomiting at an earlier visit to the pediatric emergency department should consider alternative diagnoses despite initial clinical improvement. No definitive risk factor for readmission was identified, but a high level of alertness to a possible meningeal or acute abdominal source is imperative.</description><identifier>ISSN: 1174-5878</identifier><identifier>EISSN: 1179-2019</identifier><identifier>DOI: 10.1007/s40272-022-00556-5</identifier><identifier>PMID: 36696025</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Abdomen ; Antiemetics ; Antiemetics - therapeutic use ; Child ; Children &amp; youth ; Emergency medical care ; Emergency Service, Hospital ; Gastroenteritis ; Hospitalization ; Hospitals ; Humans ; Internal Medicine ; Intestinal obstruction ; Medical records ; Medicine ; Medicine &amp; Public Health ; Meningitis ; Ondansetron - adverse effects ; Original Research Article ; Ovaries ; Patients ; Pediatrics ; Pharmacotherapy ; Physicians ; Pneumonia ; Regression analysis ; Retrospective Studies ; Risk factors ; Vomiting ; Vomiting - drug therapy ; Vomiting - etiology</subject><ispartof>Paediatric drugs, 2023-03, Vol.25 (2), p.233-238</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</rights><rights>Copyright Springer Nature B.V. Mar 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-6c73e5c474f56d16e981c22600fa79773a436bdeee86a011ad07a78dc5b98f413</cites><orcidid>0000-0001-9706-5721</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40272-022-00556-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40272-022-00556-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36696025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Palnizky Soffer, Gili</creatorcontrib><creatorcontrib>Schnapp, Zeev</creatorcontrib><creatorcontrib>Miroluz, Dana</creatorcontrib><creatorcontrib>Rimon, Ayelet</creatorcontrib><title>Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department</title><title>Paediatric drugs</title><addtitle>Pediatr Drugs</addtitle><addtitle>Paediatr Drugs</addtitle><description>Objectives We evaluated the characteristics and sought risk factors for hospitalization in children who return to the emergency department within 7 days of discharge after oral or intravenous ondansetron treatment for vomiting. The secondary aim was to determine whether the diagnosis of any serious condition had been delayed as the result of discharge after ondansetron treatment. Methods This retrospective analysis of the medical records of children who had been treated for vomiting with ondansetron in a tertiary care pediatric emergency department and revisited the emergency department within 7 days was performed between 2017 and 2019. We compared demographic and clinical features as well as management between hospitalized and discharged patients, focusing upon potentially delayed diagnoses of serious conditions. Results Fifty of the 89 ondansetron-treated children (56.2%) who revisited the emergency department were discharged home after their second emergency department visit and the remaining 39 (43.8%) were hospitalized. No parameter of the management of the first visit was predictive of the outcome of the revisit. Five revisit patients (5.6%) were newly diagnosed with a serious condition, with intussusception and ovarian torsion being the most substantial time-sensitive delays (the other diagnoses were pneumonia and aseptic meningitis). Conclusions Physicians assessing patients who had been treated with ondansetron as supportive care for vomiting at an earlier visit to the pediatric emergency department should consider alternative diagnoses despite initial clinical improvement. No definitive risk factor for readmission was identified, but a high level of alertness to a possible meningeal or acute abdominal source is imperative.</description><subject>Abdomen</subject><subject>Antiemetics</subject><subject>Antiemetics - therapeutic use</subject><subject>Child</subject><subject>Children &amp; youth</subject><subject>Emergency medical care</subject><subject>Emergency Service, Hospital</subject><subject>Gastroenteritis</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Intestinal obstruction</subject><subject>Medical records</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Meningitis</subject><subject>Ondansetron - adverse effects</subject><subject>Original Research Article</subject><subject>Ovaries</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Pharmacotherapy</subject><subject>Physicians</subject><subject>Pneumonia</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Vomiting</subject><subject>Vomiting - drug therapy</subject><subject>Vomiting - etiology</subject><issn>1174-5878</issn><issn>1179-2019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kM1uGyEURlHVqPlpX6CLCqnrSS8wwMwyctwmUqREStotwnDHIcqAC2NF3ufBg-003WWBQJfvfFc6hHxlcMoA9I_SAte8AV4PSKka-YEcMab7hgPrP-7ebSM73R2S41IeAJgWin8ih0KpXgGXR-T5PNhlTCUUmgZ6izmkdaGzFH2YQoqFnuOj3aCnIdKzUpILdjunT2G6p9fR21hwynVwl9FOI8aJDinTP2msfFxuseke6Q36Cubg6HzEvMToNrV5ZfMO-UwOBvtY8MvrfUJ-_5zfzS6aq-tfl7Ozq8YJgKlRTguUrtXtIJVnCvuOOc4VwGB1r7WwrVALj4idssCY9aCt7ryTi74bWiZOyPd97yqnv2ssk3lI6xzrSsO11q1oWadriu9TLqdSMg5mlcNo88YwMFvxZi_eVPFmJ97ICn17rV4vRvRvyD_TNSD2gVK_4hLz_93v1L4Ax6qP9g</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Palnizky Soffer, Gili</creator><creator>Schnapp, Zeev</creator><creator>Miroluz, Dana</creator><creator>Rimon, Ayelet</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0001-9706-5721</orcidid></search><sort><creationdate>20230301</creationdate><title>Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department</title><author>Palnizky Soffer, Gili ; Schnapp, Zeev ; Miroluz, Dana ; Rimon, Ayelet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-6c73e5c474f56d16e981c22600fa79773a436bdeee86a011ad07a78dc5b98f413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abdomen</topic><topic>Antiemetics</topic><topic>Antiemetics - therapeutic use</topic><topic>Child</topic><topic>Children &amp; youth</topic><topic>Emergency medical care</topic><topic>Emergency Service, Hospital</topic><topic>Gastroenteritis</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Intestinal obstruction</topic><topic>Medical records</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Meningitis</topic><topic>Ondansetron - adverse effects</topic><topic>Original Research Article</topic><topic>Ovaries</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Pharmacotherapy</topic><topic>Physicians</topic><topic>Pneumonia</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Vomiting</topic><topic>Vomiting - drug therapy</topic><topic>Vomiting - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palnizky Soffer, Gili</creatorcontrib><creatorcontrib>Schnapp, Zeev</creatorcontrib><creatorcontrib>Miroluz, Dana</creatorcontrib><creatorcontrib>Rimon, Ayelet</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Paediatric drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palnizky Soffer, Gili</au><au>Schnapp, Zeev</au><au>Miroluz, Dana</au><au>Rimon, Ayelet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department</atitle><jtitle>Paediatric drugs</jtitle><stitle>Pediatr Drugs</stitle><addtitle>Paediatr Drugs</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>25</volume><issue>2</issue><spage>233</spage><epage>238</epage><pages>233-238</pages><issn>1174-5878</issn><eissn>1179-2019</eissn><abstract>Objectives We evaluated the characteristics and sought risk factors for hospitalization in children who return to the emergency department within 7 days of discharge after oral or intravenous ondansetron treatment for vomiting. The secondary aim was to determine whether the diagnosis of any serious condition had been delayed as the result of discharge after ondansetron treatment. Methods This retrospective analysis of the medical records of children who had been treated for vomiting with ondansetron in a tertiary care pediatric emergency department and revisited the emergency department within 7 days was performed between 2017 and 2019. We compared demographic and clinical features as well as management between hospitalized and discharged patients, focusing upon potentially delayed diagnoses of serious conditions. Results Fifty of the 89 ondansetron-treated children (56.2%) who revisited the emergency department were discharged home after their second emergency department visit and the remaining 39 (43.8%) were hospitalized. No parameter of the management of the first visit was predictive of the outcome of the revisit. Five revisit patients (5.6%) were newly diagnosed with a serious condition, with intussusception and ovarian torsion being the most substantial time-sensitive delays (the other diagnoses were pneumonia and aseptic meningitis). Conclusions Physicians assessing patients who had been treated with ondansetron as supportive care for vomiting at an earlier visit to the pediatric emergency department should consider alternative diagnoses despite initial clinical improvement. No definitive risk factor for readmission was identified, but a high level of alertness to a possible meningeal or acute abdominal source is imperative.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>36696025</pmid><doi>10.1007/s40272-022-00556-5</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9706-5721</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1174-5878
ispartof Paediatric drugs, 2023-03, Vol.25 (2), p.233-238
issn 1174-5878
1179-2019
language eng
recordid cdi_proquest_journals_2777434187
source MEDLINE; SpringerNature Journals
subjects Abdomen
Antiemetics
Antiemetics - therapeutic use
Child
Children & youth
Emergency medical care
Emergency Service, Hospital
Gastroenteritis
Hospitalization
Hospitals
Humans
Internal Medicine
Intestinal obstruction
Medical records
Medicine
Medicine & Public Health
Meningitis
Ondansetron - adverse effects
Original Research Article
Ovaries
Patients
Pediatrics
Pharmacotherapy
Physicians
Pneumonia
Regression analysis
Retrospective Studies
Risk factors
Vomiting
Vomiting - drug therapy
Vomiting - etiology
title Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A18%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20of%20Serious%20Conditions%20Delayed%20in%20Association%20with%20Ondansetron%20Treatment%20for%20Vomiting%20in%20the%20Pediatric%20Emergency%20Department&rft.jtitle=Paediatric%20drugs&rft.au=Palnizky%20Soffer,%20Gili&rft.date=2023-03-01&rft.volume=25&rft.issue=2&rft.spage=233&rft.epage=238&rft.pages=233-238&rft.issn=1174-5878&rft.eissn=1179-2019&rft_id=info:doi/10.1007/s40272-022-00556-5&rft_dat=%3Cproquest_cross%3E2777434187%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2777434187&rft_id=info:pmid/36696025&rfr_iscdi=true